Abbott Laboratories recalled the weight loss drug Sibutramime in Canada and the U.S. due to links to serious side effects in some patients. Primary risks for patients include heart attacks and strokes in patients whom have a history of heart disease.
Sibutramime was banned along with other anti-obesity drugs in Europe in January. Health Canada has warned Canadian citizens of the risks associated with Sibutramime and has not recommended it’s use in patients with existing heart disease.
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or pharmaceuticals, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.